press releases rule

Archives: Search / 2015 / 2014 / 2013 / 2012 / 2011 / 2010 / 2009 / 2008

Dec 30, 2014
-- On Schedule to Release Topline Data from Phase 1b Clinical Trial and to Start Phase 2 Clinical Trial of SYN-004 in 1Q 2015 --
Dec 22, 2014
-- First-in-Class Drug Candidate to Prevent C. difficile Ahead of Schedule for Phase 2 Testing to Begin in 1st Quarter 2015 --
Dec 2, 2014
-- First-in-Class Clinical Program Targets Protection of Microbiome to Prevent Overgrowth of Deadly C. difficile Infection Linked with Use of IV Antibiotics --
Nov 24, 2014
-- Phase 1a and 1b Trials to Use SYN-004 to Protect Microbiome; Intended to Prevent Overgrowth of Potentially Deadly C. difficile Bacteria --
 

Print Email RSS